CELF2-DT

Across TCGA pan-cancer cohorts, CELF2-DT RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CELF2-DT’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CELF2-DT RNA is repressed in tumor relative to normal tissue. In most cancer types CELF2-DT is over-expressed in tumor, although a few such as KIRC and PRAD show the opposite, repressed pattern.

KIRC, PRAD, and BRCA are the cancer types where CELF2-DT tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CELF2-DT RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	−0.026	.001	6	view →
PRAD	All	All	−0.062	.015	2	view →
BRCA	All	II,III,IV	+0.023	.018	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CELF2-DT–KIRC

Open the KIRC breakdown →